Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis

被引：2

作者：

Ardizzoia, Federica ^{[1
,2
,4
]}

Lorentino, Francesca ^{[1
,2
,3
]}

Bruno, Alessandro ^{[1
]}

Marktel, Sarah ^{[1
]}

Giglio, Fabio ^{[1
]}

Clerici, Daniela ^{[1
]}

Farina, Francesca ^{[1
]}

Mastaglio, Sara ^{[1
]}

Piemontese, Simona ^{[1
]}

Assanelli, Andrea A. ^{[1
]}

Carrabba, Matteo G. ^{[1
]}

Bernardi, Massimo ^{[1
]}

Corti, Consuelo ^{[1
]}

Peccatori, Jacopo ^{[1
]}

Ciceri, Fabio ^{[1
,2
]}

Greco, Raffaella ^{[1
]}

Lupo-Stanghellini, Maria Teresa ^{[1
]}

机构：

[1] IRCCS San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy

[2] Univ Vita Salute San Raffaele, Milan, Italy

[3] Univ Milano Bicocca, Dept Med & Surg, PhD Program Publ Hlth, Milan, Italy

[4] Univ Bologna, IRCCS Azienda Osped Univ Bologna Policlin St Orso, Ist Ematol & Oncol Medica LeA Seragnoli, Alma Mater Studiorum, Bologna, Italy

来源：

HAEMATOLOGICA | 2022年 / 107卷 / 11期

关键词：

ACUTE GVHD;

D O I：

10.3324/haematol.2022.281269

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2748 / 2751

页数：4

共 50 条

[1] Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
Ardizzoia, Federica
Lorentino, Francesca
Bruno, Alessandro
Marktel, Sarah
Giglio, Fabio
Clerici, Daniela
Farina, Francesca
Mastaglio, Sara
Piemontese, Simona
Assanelli, Andrea A.
Carrabba, Matteo G.
Bernardi, Massimo
Corti, Consuelo
Peccatori, Jacopo
Ciceri, Fabio
Greco, Raffaella
Lupo-Stanghellini, Maria Teresa
HAEMATOLOGICA, 2022, 107 : 2748 - 2751
[2] Validation of Minnesota acute graft-versus-host disease Risk Score
MacMillan, Margaret L.
DeFor, Todd E.
Holtan, Shernan G.
Rashidi, Armin
Blazar, Bruce R.
Weisdorf, Daniel J.
HAEMATOLOGICA, 2020, 105 (02) : 519 - 524
[3] Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
Ruggeri, Annalisa
Sun, Yuqian
Labopin, Myriam
Bacigalupo, Andrea
Lorentino, Francesca
Arcese, William
Santarone, Stella
Gulbas, Zafer
Blaise, Didier
Messina, Giuseppe
Ghavamzadeh, Ardeshi
Malard, Florent
Bruno, Benedetto
Diez-Martin, Jose Luis
Koc, Yener
Ciceri, Fabio
Mohty, Mohamad
Nagler, Arnon
HAEMATOLOGICA, 2017, 102 (02) : 401 - 410
[4] Post-transplant damage: chronic graft-versus-host disease
Munoz Montano, M. R.
Duran Sanchez, I. M.
Torres Munoz, R. M.
Jimenez Martinez, J.
BONE MARROW TRANSPLANTATION, 2009, 43 : S343 - S343
[5] Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies
Dulery, Remy
Brissot, Eolia
Mohty, Mohamad
BLOOD REVIEWS, 2023, 62
[6] Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease
Al-Homsi, Ahmad Samer
Roy, Tara S.
Cole, Kelli
Feng, Yuxin
Duffner, Ulrich
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (04) : 604 - 611
[7] Prophylaxis of graft-versus-host disease with cyclosporine–prednisone is associated with increased risk of chronic graft-versus-host disease
S Kumar
MG Chen
DA Gastineau
MA Gertz
DJ Inwards
MQ Lacy
A Tefferi
WS Harmsen
MR Litzow
Bone Marrow Transplantation, 2001, 27 : 1133 - 1140
[8] Post-transplant graft-versus-host lymphadenopathy
Nodit, L
Murase, N
Reyes, JD
Mazariegos, GV
Sindhi, R
Jaffe, R
LABORATORY INVESTIGATION, 2004, 84 (02) : 272 - 272
[9] Prophylaxis and treatment of acute graft-versus-host disease
Chao, NJ
Chen, BJ
SEMINARS IN HEMATOLOGY, 2006, 43 (01) : 32 - 41
[10] Sitagliptin for Prophylaxis of Acute Graft-versus-Host Disease
Cooper, Dennis L.
Strair, Roger
Jaschke, Nikolai P.
Link-Rachner, Cornelia S.
Rachner, Tilman D.
Farag, Sherif S.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14): : 1374 - 1376

← 1 2 3 4 5 →